Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
September 10, 2019
Basal Histamine H<sub>4</sub> Receptor Activation: Agonist Mimicry by the Diphenylalanine Motif
David Wifling, Christopher Pfleger, Jonas Kaindl, et al.
Journal of Medicinal Chemistry
|
May 11, 2019
Conjugation of Short Peptides to Dibenzodiazepinone-Type Muscarinic Acetylcholine Receptor Ligands Determines M<sub>2</sub>R Selectivity
Andrea Pegoli, David Wifling, Corinna G Gruber, et al.
European Journal of Medicinal Chemistry
|
February 11, 2021
Dibenzodiazepinone-type muscarinic receptor antagonists conjugated to basic peptides: Impact of the linker moiety and unnatural amino acids on M<sub>2</sub>R selectivity
Corinna G Weinhart, David Wifling, Maximilian F Schmidt, et al.
Journal of Medicinal Chemistry
|
April 3, 2020
Red-Emitting Dibenzodiazepinone Derivatives as Fluorescent Dualsteric Probes for the Muscarinic Acetylcholine M<sub>2</sub> Receptor
Xueke She, Andrea Pegoli, Corinna G Gruber, et al.
Journal of Medicinal Chemistry
|
January 30, 2016
Mimicking of Arginine by Functionalized N(ω)-Carbamoylated Arginine As a New Broadly Applicable Approach to Labeled Bioactive Peptides: High Affinity Angiotensin, Neuropeptide Y, Neuropeptide FF, and Neurotensin Receptor Ligands As Examples
Max Keller, Kilian K Kuhn, Jürgen Einsiedel, et al.
Journal of Medicinal Chemistry
|
November 8, 2021
N-Terminus to Arginine Side-Chain Cyclization of Linear Peptidic Neuropeptide Y Y<sub>4</sub> Receptor Ligands Results in Picomolar Binding Constants
Adam Konieczny, Marcus Conrad, Fabian J Ertl, et al.
Nature
|
April 20, 2018
Structural basis of ligand binding modes at the neuropeptide Y Y<sub>1</sub> receptor
Zhenlin Yang, Shuo Han, Max Keller, et al.
Interface Focus
|
December 27, 2021
Pandemic drugs at pandemic speed: infrastructure for accelerating COVID-19 drug discovery with hybrid machine learning- and physics-based simulations on high-performance computers
Agastya P Bhati, Shunzhou Wan, Dario Alfè, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
September 10, 2019
Basal Histamine H<sub>4</sub> Receptor Activation: Agonist Mimicry by the Diphenylalanine Motif
David Wifling, Christopher Pfleger, Jonas Kaindl, et al.
Journal of Medicinal Chemistry
|
May 11, 2019
Conjugation of Short Peptides to Dibenzodiazepinone-Type Muscarinic Acetylcholine Receptor Ligands Determines M<sub>2</sub>R Selectivity
Andrea Pegoli, David Wifling, Corinna G Gruber, et al.
European Journal of Medicinal Chemistry
|
February 11, 2021
Dibenzodiazepinone-type muscarinic receptor antagonists conjugated to basic peptides: Impact of the linker moiety and unnatural amino acids on M<sub>2</sub>R selectivity
Corinna G Weinhart, David Wifling, Maximilian F Schmidt, et al.
Journal of Medicinal Chemistry
|
April 3, 2020
Red-Emitting Dibenzodiazepinone Derivatives as Fluorescent Dualsteric Probes for the Muscarinic Acetylcholine M<sub>2</sub> Receptor
Xueke She, Andrea Pegoli, Corinna G Gruber, et al.
Journal of Medicinal Chemistry
|
January 30, 2016
Mimicking of Arginine by Functionalized N(ω)-Carbamoylated Arginine As a New Broadly Applicable Approach to Labeled Bioactive Peptides: High Affinity Angiotensin, Neuropeptide Y, Neuropeptide FF, and Neurotensin Receptor Ligands As Examples
Max Keller, Kilian K Kuhn, Jürgen Einsiedel, et al.
Journal of Medicinal Chemistry
|
November 8, 2021
N-Terminus to Arginine Side-Chain Cyclization of Linear Peptidic Neuropeptide Y Y<sub>4</sub> Receptor Ligands Results in Picomolar Binding Constants
Adam Konieczny, Marcus Conrad, Fabian J Ertl, et al.
Nature
|
April 20, 2018
Structural basis of ligand binding modes at the neuropeptide Y Y<sub>1</sub> receptor
Zhenlin Yang, Shuo Han, Max Keller, et al.
Interface Focus
|
December 27, 2021
Pandemic drugs at pandemic speed: infrastructure for accelerating COVID-19 drug discovery with hybrid machine learning- and physics-based simulations on high-performance computers
Agastya P Bhati, Shunzhou Wan, Dario Alfè, et al.
Page
of 2